NBHA commends FDA for continuing investigation of bisphosphonate treatment for osteop

[News]

In response to today's Perspective pieces published in the New England Journal Of Medicine, the National Bone Health Alliance (NBHA), a public-private partnership bringing together the expertise and resources of its 42 members from the private and non-profit sectors to collectively advance bone health and prevent disease, commends the U.S. Food and Drug Administration (FDA) for continuing to investigate the risks and benefits of long-term bisphosphonate treatment.

More... (http://www.news-medical.net/news/20120511/NBHA-commends-FDA-for-continuing-investigation-of-bisphosphonate-treatment-for-osteoporosis.aspx)